IMMUNOTHERAPY BRIDGE
December 1st-2nd, 2021

FACULTY

Rodabe Amaria
Assistant Professor, Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US

Paolo A. Ascierto
Director, Medical Oncology, Melanoma, Cancer Immunotherapy and Development Therapeutics Department, National Cancer Institute “Fondazione G. Pascale”, Naples, Italy

Nina Bhardwaj
Director of Immunotherapy, Waldman Chair in Cancer Research, Professor of Medicine, Hematology and Medical Oncology, The Tisch Cancer Institute, New York, NY, US

Carlo Bifulco
Medical Director, PSJH System Genomics Laboratory, Providence St. Joseph Health, Director and Member, Translational Molecular Pathology, Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, US

Sergio Bracarda
Medical Oncology Specialist, Urology Director, Dept. of Oncology and Medical & Translational Oncology Unit, Santa Maria Hospital, Terni, Italy

Joshua Brody
Associate Professor, The Mount Sinai Cancer Center, New York, NY, US

Tullia Bruno
Assistant Professor, UPMC Hillman Cancer Center, Pittsburgh, PA, US

Alfredo Budillon
Chief, Experimental Pharmacology Unit, Department of Translational Research, National Cancer Institute “Fondazione G. Pascale”, Naples, Italy

Luigi Buonaguro
Director, Innovative Immunological Models Department of Research, National Cancer Institute “Fondazione G. Pascale”, Naples, Italy

Elizabeth M. Burton
Director, Melanoma Research Planning & Development, The University of Texas MD Anderson Cancer Center, Houston, TX, US

Lisa H. Butterfield
Adjunct Professor, Microbiology and Immunology, UCSF, VP, PICI Research & Development, Parker Institute for Cancer Immunotherapy, San Francisco, CA, US

Tina Cascone
Assistant Professor, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US

Myriam Chalabi
Gastrointestinal Oncology, Molecular Oncology and Immunology, Medical Oncology Netherlands Cancer Institute, Amsterdam, the Netherlands

Sandra Demaria
Professor of Pathology and Laboratory Medicine, Professor of Radiation Oncology and Adjunct Professor at Department of Pathology, Weill Cornell Medical College and NYU School of Medicine, New York City, NY, US

Leisha Emens
Professor of Medicine, Director of Translational Immunotherapy for Women’s Cancer Research Center, UPMC Hillman Cancer Center/Magee Women’s Hospital, Co-Leader, Hillman Cancer Immunology/Immunotherapy Program, Pittsburgh, PA, US

Bernard A. Fox
Chief of Molecular and Tumor Immunology Laboratory, Robert W. Franz Cancer Research Center – Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, US

Andrew Futreal
Professor and Chair, Dept of Genomic Medicine, UT MD Anderson Cancer Center, Houston, TX, US

Jerome Galon
INSERM Laboratory of Integrative Cancer Immunology; Team labeled League Against Cancer; Cordeliers Research Center, Sorbonne University, University of Paris, Paris, France

Cesare Gridelli
Chief of Division of Medical Oncology, “S.G. Moscati” Hospital, Avellino, Italy

John B. Haanen
Consultant Medical Oncologist, CSO Immunotherapy and Staff Scientist in the Division of Immunology, Professor of Translational Immunotherapy of Cancer, Leiden University Medical Centre, Amsterdam, The Netherlands

Patrick Hwu
President & CEO, Moffitt Cancer Center, Tampa, FL, US

Elizabeth Jaffee
The Dana and Albert “Cubby” Broccoli, Professor of Oncology, Deputy Director, Sidney Kimmel Cancer Center at Johns Hopkins, Co-Director, Gastrointestinal Cancers Program, Baltimore, MD, US

Samir N. Khleif
Director of the Loop Immuno-Oncology Laboratory, Biomedical Scholar and Professor of Oncology, Georgetown University Medical School, Washington, DC, US

Tomas Kirchhoff
Associate Professor, Department of Population Health Associate Professor, Department of Environmental Medicine, Perlmutter Cancer Center, New York City, New York, US

Christopher Klebanoff
MD. Head, Breast Immunotherapy Section, Memorial Sloan Kettering Cancer Center, New York, NY, US.

Theresa LaVallee
Vice President, Translational Medicine and Regulatory Affairs, Parker Institute for Cancer Immunotherapy, San Francisco, CA, US

Aurelien Marabelle
Senior Medical Oncologist in the Drug Development Department (DITEP) and Clinical Director of the Cancer Immunotherapy Program, Institut Gustave Roussy, Villejuif, France

Ignacio Melero Bermejo
Hepatology and Gene Therapy, Center for Applied Medical Research, University of Navarra, Spain

Beth Mittendorf
Robert and Karen Hale Distinguished Chair in Surgical Oncology, Associate Chair for Research, Department of Surgery at Brigham and Women’s Hospital, Director of Breast Immuno-Oncology program and Co-Director of Breast Cancer Clinical Research Program at Dana-Farber/Brigham and Women’s Cancer Center, Boston, MA, US

Chrystal M. Paulos
Associate Professor, Director of Translational Research, Cutaneous Malignancies, Department of Surgery/Microbiology & Immunology, Winship Cancer Institute, Emory University, Atlanta, GA, US

Sandro Pignata
Director, Medical Oncology division of Uro-Gynecology department, National Cancer Institute “Fondazione G. Pascale”, Naples, Italy

Antonello Pinto
Director of the Hematological Department, SC Director of Oncological Hematology, National Cancer Institute “Fondazione G. Pascale” Naples, Italy

Michael Postow
Memorial Sloan Kettering Cancer Center, New York, NY, USA

Giuseppe Procopio

Director Genitourinary Medical Oncology Unit, National Cancer Institute, Milan, Italy

Igor Puzanov
Director, Early Phase Clinical Trials Program, Chief of Melanoma, Co-Leader, CCSG Experimental Therapeutics Program, Professor of Oncology, Department of Medicine, Roswell Park Comprehensive Cancer Center, Developmental Therapeutics, Buffalo, NY, US

Marco Ruella
Assistant Professor of Medicine, Hematology/Oncology Division and Center for Cellular Immunotherapies and Scientific Director of the Lymphoma Program, University Hospital of Pennsylvania, Philadelphia, PA, US

Dirk Schadendorf
Director & Chair, Department of Dermatology & Director, Comprehensive Cancer Center at University Hospital, Essen, Germany

Robert Schreiber
Andrew M. and Jane M. Bursky Distinguished Professor, Pathology & Immunology, Interim Chief, Division of Immunobiology, Director, Center for Human Immunology and Immunotherapy Programs, Co-Leader, Tumor Immunology Program Siteman comprehensive, Cancer Center Director, T32 Training Grant in the Immunobiology and Cell Biology of Cancer (NCI), Washington University, St. Louis, MO, US

Richard Scolyer
Senior Staff Specialist, Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Co- Medical Director, Melanoma Institute Australia, Conjoint Professor, Central Clinical School, Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia

Padmanee Sharma
Professor, Departments of Genitourinary Medical Oncology and Immunology, Division of Cancer Medicine, UT MD Anderson Cancer Center, Houston, TX, US

Jeffrey A. Sosman
Professor, Medicine, Hematology Oncology Division, Feinberg School of Medicine, Northwestern University, Chicago, IL, US

Inge Marie Svane
Professor, MD, Director, National Center for Cancer Immune Therapy, CCIT-DK , Department of Oncology, Copenahagen University Hospital, Herlev, Denmark

Janis Taube
Director, Division of Dermatopathology, Professor of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, US